U.S. markets open in 6 hours 59 minutes

Teleflex Incorporated (TFX)

NYSE - NYSE Delayed Price. Currency in USD
243.42+2.38 (+0.99%)
At close: 04:04PM EST
243.42 0.00 (0.00%)
After hours: 04:33PM EST

Teleflex Incorporated

550 East Swedesford Road
Suite 400
Wayne, PA 19087-1603
United States
610 225 6800

IndustryMedical Instruments & Supplies
Full Time Employees14,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Liam J. KellyChairman, Pres & CEO3.01M5.24M1967
Mr. Thomas E. PowellExec. VP & CFO1.44MN/A1962
Mr. Cameron P. HicksCorp. VP & Chief HR Officer771.45k2.87M1965
Mr. Jay WhiteCorp. VP & Pres of Global Commercial1.23MN/A1974
Mr. John R. DerenCorp. VP & Chief Accounting OfficerN/AN/AN/A
Mr. John Hsu C.F.A.VP of Investor RelationsN/AN/AN/A
Mr. Daniel V. LogueCorp. VP, Gen. Counsel & Sec.N/AN/A1974
Mr. Howard CyrCorp. VP & Chief Compliance OfficerN/AN/AN/A
Mr. Matt TomkinVP of Corp. Devel.N/AN/AN/A
Ms. Michelle FoxCorp. VP & Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Corporate Governance

Teleflex Incorporated’s ISS Governance QualityScore as of January 28, 2023 is 8. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 8; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.